The board of Biofil Chemicals and Pharmaceuticals Limited is seeking shareholder approval through postal ballot for three significant resolutions: the appointment of Mr. Meet Shah as a Promoter Non-Executive Non-Independent Director, and the sale of certain assets to related parties—specifically, plant and machinery to Cyano Pharma Private Limited and leasehold land rights and building to Formo Plast Private Limited. The process will utilize remote e-voting, with key dates including the commencement of voting on February 20, 2025, and its conclusion on February 21, 2025. The results will be declared on or before March 22, 2025. This move indicates a positive strategic alignment with related parties, although potential risks linked to asset disposition should be monitored closely.
All announcements from Biofil Chemicals & Pharmaceuticals Limited